Parabase Offering Dx Exome, Plans to Launch Targeted Newborn Test This Quarter | GenomeWeb

Parabase Genomics is now offering a diagnostic exome test for rare genetic diseases and is planning to launch this quarter a targeted sequencing-based test that assesses 227 genes related to around 217 genetic disorders in newborns.

Parabase began offering its exome test, dubbed LifeTime RareDx, at the beginning of the year and uses Illumina's HiSeq 2500 sequencing platform.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.